Forty Seven Inc. and Acerta Enter Collaboration to Evaluate Novel Immuno-Oncology Triple Combination in Diffuse Large B-cell Lymphoma

Ads

You May Also Like

Raptor Pharmaceutical to Present Data on QUINSAIR™ at European Cystic Fibrosis Conference  

NOVATO, Calif., June 07, 2016 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical ...

FDA grants Fast Track Designation for Celyad’s ischemic heart failure therapy, C-Cure®

Celyad intends to leverage this designation to accelerate the search for a strategic partnerDesignation ...

World $750+ Million Vaccine Adjuvants Market 2014-2017 & 2025

Dublin, Nov. 06, 2017 (GLOBE NEWSWIRE) -- The "Vaccine Adjuvants Market Size And Forecast ...